logo
Share SHARE
FONT-SIZE Plus   Neg

Galena Announces Collaboration With Genentech/Roche, Henry Jackson Foundation

Galena Biopharma, Inc. (GALE) announced a clinical development collaboration with Genentech/Roche and Henry Jackson Foundation for the Advancement of Military Medicine to develop NeuVax in combination with Herceptin in adjuvant breast cancer patients currently not eligible for Herceptin therapy.

As per the terms of the collaboration, Genentech and Galena will sponsor a randomized, blinded multicenter Phase 2 clinical study in adjuvant breast cancer in around 300 patients, scheduled to be initiated in the first half of 2012. Clinical studies presented by Galena Biopharma at the American Society of Clinical Oncology meeting in June 2011 demonstrated promising results of NeuVax in combination with Herceptin in preventing breast cancer recurrences.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Internet media company BuzzFeed is preparing to go public in 2018, media site Axios reported Wednesday, citing industry sources. New York-based BuzzFeed was founded in 2006 by Jonah Peretti and John Johnson III as a viral lab, focusing exclusively on tracking viral content. London Stock Exchange Group plc (LSE.L) announced the European Commission has decided to prohibit the recommended all-share merger between LSEG and Deutsche Börse (DBOEY.PK, DBOEF.PK). Despite the remedies offered by the companies, the European Commission concluded that the merger would significantly... Tinder launched a web version of its dating app, called Tinder Online, mainly focusing users in developing markets with limited storage on their mobile phones. The company also aims users in places where mobile phones are not welcome, like class rooms. Instead of swiping, they can either drag a prospective match's card to the right or left.
comments powered by Disqus
Follow RTT